EVO Stock Summary and Trading Ideas (Evotec Se - American Depositary Shares Each Representing 1/2 Of One Ordinary Share | NASDAQ:EVO)

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Evotec Se - American Depositary Shares Each Representing 1/2 Of One Ordinary Share trades on the NASDAQ stock market under the symbol EVO.

As of December 13, 2024, EVO stock price declined to $4.49 with 122,774 million shares trading.

EVO has a beta of 0.43, meaning it tends to be less sensitive to market movements. EVO has a correlation of 0.00 to the broad based SPY ETF.

EVO has a market cap of $1.59 billion. This is considered a Small Cap stock.

Last quarter Evotec Se - American Depositary Shares Each Representing 1/2 Of One Ordinary Share reported $203 million in Revenue and -$.12 earnings per share. This fell short of revenue expectation by $-6 million and missed earnings estimates by -$.04.

In the last 3 years, EVO traded as high as $25.29 and as low as $2.85.

EVO has underperformed the market in the last year with a price return of -55.5% while the SPY ETF gained +29.9%. However, in the short term, EVO had mixed performance relative to the market. It has outperformed in the last 3 months, returning +26.8% vs +7.8% return in SPY. But in the last 2 weeks, EVO shares have been beat by the market, returning -4.3% compared to an SPY return of +0.3%.

EVO support price is $4.39 and resistance is $4.85 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that EVO shares will trade within this expected range on the day.